Abacus Life, Inc. announced it has successfully closed a $150 million debt financing facility on December 10, 2024. This facility was structured with flexible terms to support the company's long-term strategic growth. The capital infusion is intended to ensure Abacus Life is well-positioned for future expansion.
This financing provides additional liquidity and capital resources for Abacus Life's operations. It enables the company to continue pursuing its growth initiatives, including the acquisition of life settlement policies and other strategic investments. This strengthens its ability to execute its business plan.
The successful closing of this debt facility demonstrates the company's ability to attract capital and manage its financial structure effectively. It supports the ongoing execution of its business strategy as a pioneering global alternative asset manager.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.